Constitutive activation of Bruton's tyrosine kinase induces the formation of autoreactive IgM plasma cells

被引:25
|
作者
Kersseboom, Rogier [2 ]
Kil, Laurens [1 ]
Flierman, Roelof [3 ]
van der Zee, Marten [2 ]
Dingjan, Gemma M. [2 ]
Middendorp, Sabine [2 ]
Maas, Alex [4 ]
Hendriks, Rudi W. [1 ]
机构
[1] Erasmus MC, Dept Pulm Med, NL-3000 CA Rotterdam, Netherlands
[2] Erasmus MC, Dept Immunol, NL-3000 CA Rotterdam, Netherlands
[3] Leiden Univ, Med Ctr, Dept Nephrol, NL-2300 RA Leiden, Netherlands
[4] Erasmus MC, Dept Cell Biol & Genet, NL-3000 CA Rotterdam, Netherlands
关键词
Antibodies; Autoimmunity; B cells; B cell-development; Signal transduction; B-CELLS; POSITIVE SELECTION; AUTOANTIBODY PRODUCTION; SIGNALING THRESHOLDS; AUTOIMMUNE-DISEASE; DEFICIENT MICE; BTK FUNCTION; B-1; CELLS; CD19; LYMPHOCYTES;
D O I
10.1002/eji.201040521
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
B-cell receptor (BCR)-mediated signals provide the basis for B-cell differentiation in the BM and subsequently into follicular, marginal zone, or B-1 B-cell subsets. We have previously shown that B-cell-specific expression of the constitutive active E41K mutant of the BCR-associated molecule Bruton's tyrosine kinase (Btk) leads to an almost complete deletion of immature B cells in the BM. Here, we report that low-level expression of the E41K or E41K-Y223F Btk mutants was associated with reduced follicular B-cell numbers and significantly increased proportions of B-1 cells in the spleen. Crosses with 3-83 mu delta and VH81X BCR Tg mice showed that constitutive active Btk expression did not change follicular, marginal zone, or B-1 B-cell fate choice, but resulted in selective expansion or survival of B-1 cells. Residual B cells were hyperresponsive and manifested sustained Ca2+ mobilization. They were spontaneously driven into germinal center-independent plasma cell differentiation, as evidenced by increased numbers of IgM(+) plasma cells in spleen and BM and significantly elevated serum IgM. Because anti-nucleosome autoantibodies and glomerular IgM deposition were present, we conclude that constitutive Btk activation causes defective B-cell tolerance, emphasizing that Btk signals are essential for appropriate regulation of B-cell activation.
引用
收藏
页码:2643 / 2654
页数:12
相关论文
共 50 条
  • [41] Decoding bruton's tyrosine kinase signalling in neuroinflammation
    Gruber, R.
    Dufault, M.
    Chretien, N.
    Proto, J.
    Zhang, M.
    Lamorte, M.
    Havari, E.
    Turner, T.
    Chomyk, A.
    Christie, E.
    Trapp, B.
    Ofengeim, D.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 270 - 270
  • [42] Bruton's tyrosine kinase in systemic lupus erythematosus
    Liao, Hsien-Tzung
    Tung, Hsiang-Yuen
    Tsai, Chang-Youh
    Chiang, Bor-Luen
    Yu, Chia-Li
    JOINT BONE SPINE, 2020, 87 (06) : 670 - 672
  • [43] Distinct Roles for Bruton's Tyrosine Kinase in B Cell Immune Synapse Formation
    Roman-Garcia, Sara
    Merino-Cortes, Sara V.
    Gardeta, Sofia R.
    de Bruijn, Marjolein J. W.
    Hendriks, Rudi W.
    Carrasco, Yolanda R.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [44] Bruton's tyrosine kinase regulates the activation of gene rearrangements at the λ light chain locus in precursor B cells in the mouse
    Dingjan, GM
    Middendorp, S
    Dahlenborg, K
    Maas, A
    Grosveld, F
    Hendriks, RW
    JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (10): : 1169 - 1178
  • [45] Clinical potential of targeting Bruton's tyrosine kinase
    Uckun, Fatih M.
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2008, 27 (1-2) : 43 - 69
  • [46] Dermatological Toxicities of Bruton’s Tyrosine Kinase Inhibitors
    Vincent Sibaud
    Marie Beylot-Barry
    Caroline Protin
    Emmanuelle Vigarios
    Christian Recher
    Loic Ysebaert
    American Journal of Clinical Dermatology, 2020, 21 : 799 - 812
  • [47] Role of Bruton's tyrosine kinase in macrophage apoptosis
    Khare, Anupriya
    Viswanathan, Bharathi
    Gund, Rupali
    Jain, Nidhi
    Ravindran, Balachandran
    George, Anna
    Rath, Satyajit
    Bal, Vineeta
    APOPTOSIS, 2011, 16 (04) : 334 - 346
  • [48] Bruton's Tyrosine Kinase and Its Isoforms in Cancer
    Wang, Xianhui
    Kokabee, Leila
    Kokabee, Mostafa
    Conklin, Douglas S.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [49] Dermatological Toxicities of Bruton's Tyrosine Kinase Inhibitors
    Sibaud, Vincent
    Beylot-Barry, Marie
    Protin, Caroline
    Vigarios, Emmanuelle
    Recher, Christian
    Ysebaert, Loic
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2020, 21 (06) : 799 - 812
  • [50] Bruton's tyrosine kinase: What's known now
    Kawakami, T
    Kitaura, J
    Kawakami, Y
    SEIKAGAKU, 1998, 70 (10): : 1262 - 1266